134 results
Page 3 of 7
8-K
EX-3.1
nuk7swm4 rowknxt3
4 Dec 07
Acura Pharmaceuticals, Inc. Announces Implementation of
12:00am
8-K
EX-10.1
ddv27acdr4
2 Nov 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
s0u81njv
31 Oct 07
Acura Pharmaceuticals, Inc. Announces Reverse Stock Split
12:00am
S-3
2a1la81h x9t
1 Oct 07
Shelf registration
12:00am
8-K
EX-10.1
kmyi46m
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am
8-K
EX-10.1
b1ppgne
31 Jan 06
Acura Pharmaceuticals, Inc. Secures Bridge Funding
12:00am
8-K
EX-10.2
jztst6v6 1u
10 Nov 05
Acura Pharmaceuticals, Inc. Reports Financial Results
12:00am
8-K
EX-10.1
cd49y20 a2432
16 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
d5rul
23 Jun 05
Entry into a Material Definitive Agreement
12:00am